Orlistat clinical trials
Also written Alli and Xenical.
How each study uses Orlistat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Orlistat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 23 Apr 1999 · XENICAL · NDA 020766 (FDA, Drugs@FDA)
- European Union
- 29 Jul 1998 · Xenical · EMEA/H/C/000154 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
48 studies that test it; most in 2008 (6)
| Year | Studies |
|---|---|
| 1998 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 3 |
| 2007 | 1 |
| 2008 | 6 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 2 |
| 2015 | 4 |
| 2016 | 1 |
| 2018 | 3 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 11 · Other 37
University of Texas Southwestern Medical Center (3) · Yale University (3) · GlaxoSmithKline (3) · Hoffmann-La Roche (2) · University of Campinas, Brazil (2) · Pennington Biomedical Research Center (2) · Khyber Medical University Peshawar (1) · Emory University (1)
Often tested with
Tested in the same studies.
Liraglutide (5) · Sibutramine (4) · Metformin (2) · Topiramate (2) · SGLT2 inhibitors (1) · DPP-4 inhibitors (1) · Behavioral Intervention (1) · Velneperit (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 4
Studies that test Orlistat.
- Aug 2027Long Term Efficacy and Safety of Orlistat for Type 1 HyperlipoproteinemiaPhase 2 · University of Texas Southwestern Medical Center
- Aug 2027RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.Phase 4 · The Fourth Affiliated Hospital of Zhejiang University School of Medicine
- Sep 2027Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical HyperplasiaPhase 2 · Peking University People's Hospital
- Nov 2027Orlistat and Weight Management for Uric Acid Control in Obese Gout: A RCTNot applicable · XueMei Guo
Studies
Open first, then newest update. How each study uses Orlistat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 48
- Long Term Efficacy and Safety of Orlistat for Type 1 HyperlipoproteinemiaRecruitingPhase 2University of Texas Southwestern Medical CenterNCT05816343Written as OrlistatHow we know
- Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical HyperplasiaNot yet recruitingPhase 2Peking University People's HospitalNCT07714070Written as OrlistatHow we know
- RWS of of Liraglutide Alone and in Combination With Orlistat for Weight Loss in Overweight/Obese Patients.Not yet recruitingPhase 4The Fourth Affiliated Hospital of Zhejiang University School of MedicineNCT07301437Written as liraglutide combined with orlistatHow we know
- Orlistat and Weight Management for Uric Acid Control in Obese Gout: A RCTNot yet recruitingNot applicableXueMei GuoNCT07326839Written as Orlistat 120 mgHow we know
- Orlistat Overcoming Third-generation EGFR-TKI ResistanceNot yet recruitingPhase 2Ping PengNCT06818955Written as Orlistat 120 mgHow we know
- Efficacy and Safety of Liraglutide in the Treatment of Obesity Combined With Metabolism Associated Fatty Liver DiseaseRecruitingPhase 4Affiliated Hospital of Nantong UniversityNCT06501326Written as OrlistatHow we know
- Effect of Orlistat on Metabolic and Hormonal Features in Women With Polycystic Ovary Syndrome (PCOS)CompletedNot applicableKhyber Medical University PeshawarNCT07747909Written as OrlistatHow we know
- Weight Loss Aid in an Exposed PopulationCompletedPhase 4Emory UniversityNCT03582722Written as OrlistatHow we know
- Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With ObesityTerminatedPhase 2University of IowaNCT01351753Written as OrlistatHow we know
- EMI-EHP Weight Management and Type 2 Diabetes Pragmatic TrialTerminatedPhase 4The Cleveland ClinicNCT04531176Written as OrlistatHow we know
- Orlistat Reduces Uric Acid in Overweight/Obese Patients With HyperuricemiaCompletedPhase 4Shanghai 10th People's HospitalNCT05496075Written as OrlistatHow we know
- Orlistat for the Treatment of Type I HyperlipoproteinemiaCompletedPhase 2University of Texas Southwestern Medical CenterNCT02767531Written as OrlistatHow we know
- Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical TreatmentCompletedPhase 4Khoo Teck Puat HospitalNCT02041234Written as XenicalHow we know
- Improving Reproductive Fitness Through Pretreatment With Lifestyle Modification in Obese Women With Unexplained InfertilityCompletedPhase 3Yale UniversityNCT02432209Written as OrlistatHow we know
- Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mgCompletedNot applicableShandong New Time Pharmaceutical Co., LTDNCT05076474Written as Orlistat 60mg CapHow we know
- Phase 2 Study of Orlistat and SLx-4090 for the Treatment of Type 1 HyperlipoproteinemiaTerminatedPhase 2University of Texas Southwestern Medical CenterNCT01675154Written as OrlistatHow we know
- Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) PatientsCompletedPhase 2Yazd Research & Clinical Center for InfertilityNCT01003483Written as orlistatHow we know
- Evaluation of Orlistat as Adjuvant Treatment of Obesity in AdultsCompletedPhase 3EMSNCT01755676Written as Orlistat 60 mgHow we know
- Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped CareCompletedNot applicableYale UniversityNCT00829283Written as Sibutramine/OrlistatHow we know
- Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic PersonsCompletedPhase 4Yale UniversityNCT00516919Written as Xenical + behavioral interventionHow we know
See all 48 studies that test Orlistat →
Given beside what is tested · 2 — Orlistat is usual care or a partner of the new treatment
- Effect of Electroacupuncture on Central Obesity and Fatty Liver in Postmenopausal WomenCompletedNot applicableCairo UniversityNCT07437001Written as Medical treatmentHow we know
- Adding Guided Self-Help Group Therapy to the Alli Weight Loss Program in Treating Binge Eating DisorderCompletedNot applicableStanford UniversityNCT00601354Written as Orlistat/alli programHow we know
As the comparator · 6 — what is tested is compared with Orlistat
- A Trial With EMP16 in Preparation for Late Phase StudiesNot yet recruitingPhase 2Empros Pharma ABNCT06993428Written as Alli® 60 mgHow we know
- A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in AmericaCompletedPhase 4Novo Nordisk A/SNCT05579249Written as OrlistatHow we know
- Anti-obesity Effects of Dandelion (Taraxacum Officinale L.)CompletedNot applicableOctober 6 UniversityNCT06625736Written as XenicalHow we know
- Study Exploring the Supportive Effect of Acarbose in Weight ManagementActive, not recruitingPhase 2Empros Pharma ABNCT05934110Written as Conventional orlistat 120 mg,How we know
- The Effect of Liraglutide on Body Weight in Obese Subjects Without DiabetesCompletedPhase 2Novo Nordisk A/SNCT00422058Written as orlistatHow we know
- A Low-Carbohydrate, Ketogenic Diet Versus Orlistat for Weight LossCompletedNot applicableUS Department of Veterans AffairsNCT00108524Written as OrlistatHow we know
Codes
What other systems call Orlistat · ClinicalTrials.gg INT006713
- MeSH (NLM) D000077403OrlistatConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 95M8R751W8ORLISTATConfirmed FDA, NLM, Wikidata
- RxNorm 37925Confirmed FDA, Wikidata
- Wikidata Q424163orlistatConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29303OrlistatOne source FDA
- DrugBank DB01083One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077403 | Orlistat | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 95M8R751W8 | ORLISTAT | Confirmed FDA, NLM, Wikidata |
| RxNorm | 37925 | — | Confirmed FDA, Wikidata |
| Wikidata | Q424163 | orlistat | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29303 | Orlistat | One source FDA |
| DrugBank | DB01083 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.